Miwa, S. https://orcid.org/0000-0002-5962-8287
Nojima, T.
Alomesen, A. A.
Ikeda, H.
Yamamoto, N.
Nishida, H.
Hayashi, K.
Takeuchi, A.
Igarashi, K.
Higuchi, T.
Yonezawa, H.
Araki, Y.
Morinaga, S.
Asano, Y.
Tsuchiya, H.
Funding for this research was provided by:
Uehara Memorial Foundation (201820136)
Article History
Received: 17 December 2020
Accepted: 26 January 2021
First Online: 26 February 2021
Compliance with ethical standards
:
: The authors declare that they have no competing interests.
: All procedures performed in the study involving human participants were in accordance with the ethical standards of the Trust and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: This study was approved by the Institutional Review Board of Kanazawa University Hospital on August 6, 2019 (IRB number 2019-031). All study patients consented to participate in the clinical trial and further studies using their clinical records, radiological images, and tumor specimens when they received immunotherapy. The need for informed consent in this study was waived by the Ethics Committee.